As of Feb 4, 2025, the Zoetis stock's price-to-earnings ratio is 32.32. This results from the current EPS of $5.33 and stock price of $172.24. The PE ratio has decreased by 9% from the past four quarters average of 35.5.
The PE ratio of Zoetis has averaged 40.68 over the last ten years. The current P/E ratio of 32.32 is 21% lower than the historical average. In the past ten years, ZTS's PE ratio peaked in the Dec 2015 quarter at 70.47, when the stock price was $47.92 and the EPS was $0.68. The lowest point was in the Dec 2018 quarter, when it reached 28.9 with a price of $85.54 and an EPS of $2.96.
Maximum annual increase: 90% in 2015
Maximum annual decrease: -54.24% in 2016
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2023 | 38.85 | 19.58% | $197.37 | $5.08 |
2022 | 32.49 | -42.88% | $146.55 | $4.51 |
2021 | 56.88 | 18.23% | $244.03 | $4.29 |
2020 | 48.11 | 14.14% | $165.5 | $3.44 |
2019 | 42.15 | 45.85% | $132.35 | $3.14 |
2018 | 28.9 | -29.39% | $85.54 | $2.96 |
2017 | 40.93 | 26.91% | $72.04 | $1.76 |
2016 | 32.25 | -54.24% | $53.53 | $1.66 |
2015 | 70.47 | 90% | $47.92 | $0.68 |
2014 | 37.09 | 14.58% | $43.03 | $1.16 |
2013 | 32.37 | N/A | $32.69 | $1.01 |
2012 | N/A | N/A | N/A | $0.87 |
2011 | N/A | N/A | N/A | $0.49 |
2010 | N/A | N/A | N/A | $0.22 |
2009 | N/A | N/A | N/A | N/A |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Sep 2024 | 36.66 | 8.05% | $195.38 | $5.33 |
Jun 2024 | 33.93 | 4.08% | $173.36 | $5.11 |
Mar 2024 | 32.6 | -16.09% | $169.21 | $5.19 |
Dec 2023 | 38.85 | 9.87% | $197.37 | $5.08 |
Sep 2023 | 35.36 | -2.27% | $173.98 | $4.92 |
Jun 2023 | 36.18 | -3.49% | $172.21 | $4.76 |
Mar 2023 | 37.49 | 15.39% | $166.44 | $4.44 |
Dec 2022 | 32.49 | -3.82% | $146.55 | $4.51 |
Sep 2022 | 33.78 | -13.14% | $148.29 | $4.39 |
Jun 2022 | 38.89 | -9.89% | $171.89 | $4.42 |
Mar 2022 | 43.16 | -24.12% | $188.59 | $4.37 |
Dec 2021 | 56.88 | 22.16% | $244.03 | $4.29 |
Sep 2021 | 46.56 | 0.43% | $194.14 | $4.17 |
Jun 2021 | 46.36 | 9.81% | $186.36 | $4.02 |
Mar 2021 | 42.22 | -12.24% | $157.48 | $3.73 |
The current PE ratio of ZTS is lower than the 3, 5 and 10-year averages.
In comparison to its peers LLY and PFE, ZTS's PE ratio is lower, but it is higher than MRK's. Zoetis's PE ratio is trading below the peer group average of 48.28.
Stock name | PE ratio | Market cap |
---|---|---|
MRK Merck & Co Inc | 18.94 | $229.54B |
ZTS Zoetis Inc | 32.32 | $77.71B |
PFE Pfizer Inc | 34.04 | $146.61B |
PAHC Phibro Animal Health Corp | 51.21 | $891.89M |
LLY ELI LILLY & Co | 88.92 | $784.2B |
ICCC Immucell Corp | N/A | $46.34M |
ZTS stock has a price to earnings ratio of 32.32 as of Feb 4, 2025.
The 3-year average price to earnings ratio for ZTS stock is 36.31.
The 5-year average price to earnings ratio for ZTS stock is 40.1.
The highest quarterly PE ratio in the last ten years has been 70.47 and it was in the Dec 2015 quarter.
ZTS's price to earnings ratio is currently 21% below its 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Feb 4, 2025), Zoetis's stock price is $172.24. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $5.33. Therefore, Zoetis's PE ratio for today is 32.32. PE RATIO(32.32) = STOCK PRICE($172.24) / TTM EPS($5.33)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.